NEW YORK, May 9, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
European Market for Interventional Cardiology Devices
Despite turbulent macroeconomic conditions in recent years, the European market for interventional
cardiology devices is expected to remain stable over the forecast period.
Advancements in specific technologies and practices such as drug management, drug-eluting stents, specialty guidewires, micro-introducer sheaths, fractional flow reserve guidewires and various imaging modalities will account for a great deal of the growth in the total market for interventional cardiology devices. Many of the established standard products have essentially become commodities and are close to homogeneous in their substitutability. Thus the responsibility will remain with new or specialized devices that receive positive clinical trials to act as catalysts for growth and to increase the market share of companies that are able to capitalize on such opportunities. For established items such as catheters, guidewires and introducers, companies will have the opportunity to utilize distribution networks as well as the bundling of multiple products in order to increase revenues.
Scope:
This report pertains to a forecast period of 10 years (2009- 2019) for the following countries:
• Germany
• France
• the United Kingdom (U.K.)
• Italy
• Spain
• Benelux (Belgium, Netherlands, and Luxembourg),
• Scandinavia (Finland, Denmark, Sweden, and Norway)
• Portugal
• Austria
• Switzerland
Report Contents:
Competitor Analysis
Identified Strategic Opportunities
Market Overview by Segment & Country
Trend Analysis by Segment & Country
Market Drivers & Limiters
Mergers & Acquisitions
Customer Feedback and Market Monitoring
Main Segments Included:
• Drug-eluting stents
• Bare-metal stents
• PTCA balloon catheters
• Interventional coronary catheters and guidewires
• Diagnostic coronary catheters and guidewires
• Coronary introducer sheaths
• Embolic protection devices
• Atherectomy devices
• Coronary vascular closure devices
• Optical coherence tomography (OCT) catheters
• Intravascular ultrasound (IVUS) catheters
• In addition, this report covers the emerging markets for vulnerable plaque screening and treatment.
Companies Included:
Abbott Laboratories
Cordis
St. Jude Medical
Terumo
Medtronic
Volcano Therapeutics
Biotronik
AccessClosure
Hexacath
Boston Scientific
Sorin
B. Braun
Spectranetics
Reasons To Buy:
This report analyzes and evaluates the current state of the European interventional cardiology devices market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our "bottom up" approach, which includes primary and secondary research methods.
TABLE OF CONTENTS I
LIST OF FIGURES X
LIST OF CHARTS XXI
EXECUTIVE SUMMARY 1
1.1 INTERVENTIONAL CARDIOLOGY DEVICE MARKET 1
1.2 TREND ANALYSIS BY COUNTRY 3
1.3 PROCEDURE NUMBERS 4
1.4 CORONARY STENT MARKET 5
1.5 PTCA BALLOON MARKET 6
1.6 INTERVENTIONAL CORONARY CATHETER & GUIDEWIRE MARKET 7
1.7 CORONARY INTRODUCER SHEATH MARKET 8
1.8 CORONARY EMBOLIC PROTECTION DEVICE MARKET 9
1.9 CORONARY ATHERECTOMY DEVICE MARKET 10
1.10 DIAGNOSTIC CORONARY CATHETER & GUIDEWIRE MARKET 11
1.11 FRACTIONAL FLOW RESERVE GUIDEWIRE MARKET 12
1.12 CORONARY VASCULAR CLOSURE DEVICE MARKET 13
1.13 IVUS CATHETER MARKET 14
1.14 OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICE MARKET 15
1.15 VULNERABLE PLAQUE DEVICE MARKET 16
1.16 COMPETITIVE ANALYSIS 17
RESEARCH METHODOLOGY 18
2.1 RESEARCH SCOPE 18
2.2 IDATA'S 9-STEP METHODOLOGY 18
Step 1: Project Initiation & Team Selection 19
Step 2: Prepare Data Systems and Perform Secondary Research 21
Step 3: Preparation for Interviews & Questionnaire Design 22
Step 4: Performing Primary Research 23
Step 5: Research Analysis: Establishing Baseline Estimates 25
Step 6: Market Forecast and Analysis 26
Step 7: Identify Strategic Opportunities 28
Step 8: Final Review and Market Release 29
Step 9: Customer Feedback and Market Monitoring 30
EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKETS 31
3.1 INTRODUCTION 31
3.1.1 Population at Risk 31
3.2 CURRENCY EXCHANGE RATE 33
3.3MARKET OVERVIEW 34
3.4MARKET BY SEGMENT 37
3.4.1 Market Concentration 44
3.5MARKET BY COUNTRY 46
3.5.1.1 Germany 46
3.5.1.2 France 46
3.5.1.3 United Kingdom 46
3.5.1.4 Italy 47
3.5.1.5 Spain 47
3.5.1.6 Benelux 47
3.5.1.7 Scandinavia 48
3.5.1.8 Portugal 48
3.5.1.9 Austria 48
3.5.1.10 Switzerland 48
3.6 TREND ANALYSIS BY COUNTRY 53
3.7MARKET DRIVERS AND LIMITERS 56
3.7.1 Market Drivers 56
3.7.2 Market Limiters 56
3.8 COMPETITIVE ANALYSIS 58
3.9MERGERS AND ACQUISITIONS 62
PROCEDURE NUMBERS 63
4.1 TOTAL PROCEDURE NUMBERS 63
4.2 GERMANY 68
4.3 FRANCE 69
4.4 UNITED KINGDOM 70
4.5 ITALY 71
4.6 SPAIN 72
4.7 BENELUX 73
4.8 SCANDINAVIA 74
4.9 PORTUGAL 75
4.10 AUSTRIA 76
4.11 SWITZERLAND 77
COUNTRY PROFILES 78
5.1 INTRODUCTION 78
5.1.1 Population 78
5.1.2 GDP Per Capita 78
5.1.3 PCI and DES Penetration Rates 78
5.1.4 Price Index 78
5.2 GERMANY 80
5.3 FRANCE 81
5.4 UNITED KINGDOM 82
5.5 ITALY 83
5.6 SPAIN 84
5.7 BENELUX 85
5.8 SCANDINAVIA 86
5.9 PORTUGAL 87
5.10 AUSTRIA 88
5.11 SWITZERLAND 89
CORONARY STENT MARKET 90
6.1 INTRODUCTION 90
6.2MARKET OVERVIEW 92
6.3MARKET ANALYSIS AND FORECAST 98
6.3.1 Total Coronary Stent Market 98
6.3.2 Total Coronary Stent Units Sold by Stent Diameter 106
6.3.3 Total Coronary Stent Units Sold by Stent Length 106
6.3.4 Drug-Eluting Stent Market 107
6.3.5 Bare-Metal Stent Market 115
6.4MARKET DRIVERS AND LIMITERS 123
6.4.1 Drug-Eluting Stent Market 123
6.4.1.1 Market Drivers 123
6.4.1.2 Market Limiters 123
6.4.2 Bare-Metal Stent Market 125
6.4.2.1 Market Drivers 125
6.4.2.2 Market Limiters 125
6.5 COMPETITIVE ANALYSIS 127
6.5.1 Brands by Leading Competitors 134
6.5.2 Emerging Competitors 135
6.6 EMERGING TECHNOLOGIES 137
6.6.1 Bioabsorbable Coronary Stents 137
6.6.2 Bifurcated Coronary Stents 140
PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY BALLOON CATHETER
MARKET 141
7.1 INTRODUCTION 141
7.1.1 Balloon Types 141
7.1.2 Drug-Eluting Balloons 142
7.1.3 PTCA Balloons by Classification 143
7.2MARKET ANALYSIS AND FORECAST 144
7.3 PROCEDURES 152
7.3.1 Units per Procedure 152
7.3.2 Units Sold by Indication 153
7.4MARKET DRIVERS AND LIMITERS 156
7.4.1 Market Drivers 156
7.4.2 Market Limiters 156
7.5 COMPETITIVE ANALYSIS 158
7.5.1 Brands by Leading Competitors 162
INTERVENTIONAL CORONARY CATHETER MARKET 163
8.1 INTRODUCTION 163
8.1.1 Units per Procedure 164
8.2MARKET ANALYSIS AND FORECAST 165
8.3MARKET DRIVERS AND LIMITERS 173
8.3.1 Market Drivers 173
8.3.2 Market Limiters 173
8.4 COMPETITIVE ANALYSIS 175
8.4.1 Brands by Leading Competitors 180
INTERVENTIONAL CORONARY GUIDEWIRE MARKET 181
9.1 INTRODUCTION 181
9.1.1 Device Construction 181
9.1.2 Hydrophilic Guidewires 182
9.1.3 Units per Procedure 182
9.2MARKET ANALYSIS AND FORECAST 183
9.3MARKET DRIVERS AND LIMITERS 191
9.3.1 Market Drivers 191
9.3.2 Market Limiters 191
9.4 COMPETITIVE ANALYSIS 193
9.4.1 Brands by Leading Competitors 197
CORONARY INTRODUCER SHEATH MARKET 198
10.1 INTRODUCTION 198
10.1.1 The Femoral Approach 199
10.1.2 Radial/Brachial Approach 199
10.2MARKET OVERVIEW 200
10.2.1 Units per Procedure 205
10.2.2 Coronary Introducer Sheath Market by Access Site 206
10.3MARKET ANALYSIS AND FORECAST 208
10.3.1 Total Coronary Introducer Sheath Market 208
10.3.2 Standard Coronary Introducer Sheath Market 216
10.3.3 Coronary Micro-Introducer Sheath Market 224
10.4MARKET DRIVERS AND LIMITERS 232
10.4.1 Market Drivers 232
10.4.2 Market Limiters 232
10.5 COMPETITIVE ANALYSIS 234
10.5.1 Brands by Leading Competitors 237
CORONARY EMBOLIC PROTECTION DEVICE MARKET 238
11.1 INTRODUCTION 238
11.1.1 Saphenous Vein Grafts 238
11.2 PROTECTION MECHANISM 239
11.3MARKET ANALYSIS AND FORECAST 240
11.4MARKET DRIVERS AND LIMITERS 249
11.4.1 Market Drivers 249
11.4.2 Market Limiters 250
11.5 COMPETITIVE ANALYSIS 251
11.5.1 Brands by Leading Competitors 254
CORONARY ATHERECTOMY DEVICE MARKET 255
12.1 INTRODUCTION 255
12.1.1 Atherectomy 255
12.1.2 Device Technologies 256
12.1.2.1 Mechanical Atherectomy 256
12.1.2.2 Laser Atherectomy 256
12.1.2.3 Directional Coronary Atherectomy (DCA) 256
12.2MARKET ANALYSIS & FORECAST 257
12.3MARKET DRIVERS AND LIMITERS 265
12.3.1 Market Drivers 265
12.3.2 Market Limiters 265
12.4 COMPETITIVE ANALYSIS 267
12.4.1 Brands by Leading Competitors 270
DIAGNOSTIC CORONARY CATHETER AND GUIDEWIRE MARKET 271
13.1 INTRODUCTION 271
13.2MARKET OVERVIEW 272
13.3MARKET ANALYSIS AND FORECAST 278
13.3.1 Total Diagnostic Coronary Catheter and Guidewire Market 278
13.4 DIAGNOSTIC CATHETER MARKET 286
13.5 DIAGNOSTIC GUIDEWIRE MARKET 294
13.6MARKET DRIVERS AND LIMITERS 302
13.6.1 Market Drivers 302
13.6.2 Market Limiters 302
13.7 COMPETITIVE ANALYSIS 304
13.7.1 Brands by Leading Competitors 309
FRACTIONAL FLOW RESERVE GUIDEWIRE MARKET 310
14.1 INTRODUCTION 310
14.2MARKET ANALYSIS AND FORECAST 311
14.3MARKET DRIVERS AND LIMITERS 319
14.3.1 Market Drivers 319
14.3.2 Market Limiters 319
14.4 COMPETITIVE ANALYSIS 320
14.4.1 Brands by Leading Competitors 322
CORONARY VASCULAR CLOSURE DEVICE MARKET 323
15.1 INTRODUCTION 323
15.1.1 Invasive and Non-Invasive Devices 323
15.2MARKET OVERVIEW 324
15.3MARKET ANALYSIS AND FORECAST 330
15.3.1 Total Coronary VCD Market 330
15.3.2 Total Coronary VCD Market by Access Site 338
15.3.3 Invasive Coronary VCD Market 340
15.3.4 Non-Invasive Coronary VCD Market 348
15.4MARKET DRIVERS AND LIMITERS 356
15.4.1 Market Drivers 356
15.4.2 Market Limiters 356
15.5 COMPETITIVE ANALYSIS 358
15.5.1 Brands by Leading Competitors 361
INTRAVASCULAR ULTRASOUND CATHETER MARKET 362
16.1 INTRODUCTION 362
16.1.1 Pre-Stenting Applications 362
16.1.2 Post-Stenting Applications 363
16.1.3 IVUS Console Penetration 363
16.2MARKET ANALYSIS AND FORECAST 364
16.3 PENETRATION RATE 372
16.4MARKET DRIVERS AND LIMITERS 373
16.4.1 Market Drivers 373
16.4.2 Market Limiters 374
16.5 COMPETITIVE ANALYSIS 375
16.5.1 Brands by Leading Competitors 378
OPTICAL COHERENCE TOMOGRAPHY CATHETER MARKET 379
17.1 INTRODUCTION 379
17.1.1 OCT Applications 380
17.2MARKET ANALYSIS AND FORECAST 381
17.3 PENETRATION RATE 389
17.4MARKET DRIVERS AND LIMITERS 390
17.4.1 Market Drivers 390
17.4.2 Market Limiters 391
17.5 COMPETITIVE ANALYSIS 392
17.5.1 Bramds by Leading Competitors 393
VULNERABLE PLAQUE DEVICE MARKET 394
18.1 INTRODUCTION 394
18.1.1 Vulnerable Plaque Screening Technologies 395
18.1.1.1 Intravascular Ultrasound (IVUS) 395
18.1.1.2 Optical Coherence Tomography (OCT) 395
18.1.1.3 Raman Spectroscopy 395
18.1.1.4 Near Infrared (NIR) Spectroscopy 396
18.1.1.5 Thermography 396
18.1.1.6 Intravascular Magnetic Resonance Imaging (IVMRI) 396
18.1.1.7 Computed Tomography (CT) 396
18.1.2 Potential Vulnerable Plaque Treatments 397
18.1.2.1 Stents 397
18.1.2.2 Pharmaceuticals 397
18.1.2.3 Photodynamic Therapies 397
18.1.2.4 Cryotherapy 397
18.2 TARGET POPULATION 399
18.3MARKET ANALYSIS AND FORECAST 402
18.3.1 Total Potential Market 402
18.3.2 Potential Vulnerable Plaque Screening Market 405
18.3.3 Potential Vulnerable Plaque Treatment Market 409
18.4MARKET DRIVERS AND LIMITERS 412
18.4.1 Market Drivers 412
To order this report:
Cardiovascular_Devices Industry: European Market for Interventional Cardiology Devices
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001
SOURCE Reportlinker
Share this article